Synthesis of methotrexate-poly (ethylene glycol) conjugate and their anti-tumor activity in vitro.
- Author:
Jian-Feng ZHANG
1
;
Dong-Zhi WEI
;
Xiong ZHOU
;
Feng JIANG
Author Information
1. State Key Laboratory Base of Novel Functional Materials and Preparation Science, Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo 315211, China. zjf@nbu.edu.cn
- Publication Type:Journal Article
- MeSH:
Animals;
Antineoplastic Agents;
chemical synthesis;
Leukemia L1210;
drug therapy;
Methotrexate;
chemical synthesis;
chemistry;
pharmacology;
Mice;
Polyethylene Glycols;
chemical synthesis;
chemistry;
pharmacology;
Solubility
- From:
Acta Pharmaceutica Sinica
2007;42(6):607-610
- CountryChina
- Language:Chinese
-
Abstract:
To improve the physical property and bioactivity of methotrexate, this paper investigated the new formation of conjugate methotrexate-poly (ethylene glycol) and in vitro anti-tumor activity of the synthesized conjugate. The conjugate of methotrexate-poly (ethylene glycol), which was verified by the spectroscopy analysis of UV, IR and 13C NMR, was synthesized by chemical catalysis and micro-wave irritation. The determination for the conjugate of solubility in water and distribution coefficient in octanol-water system of the conjugate was done to examine its deliquescence property. The solubility in water and the distribution coefficient of the conjugate was greatly improved, which was increased by 128 folds and 5 folds, respectively. The in vitro anti-tumor activity of the conjugate was tested by mouse L(1210) leukaemia cells, and the synthesized conjugate showed the same anti-tumor activity as the original methotrexate. Compared to the reported literature, the modification of methotrexate by poly (ethylene glycol) is more rapid and convenient.
